クレアチニン測定の世界市場（2022年～2029年）

当レポートでは、世界のクレアチニン測定市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界のクレアチニン測定市場の調査手法と範囲

• 調査手法
• 調査の目的と調査範囲

第2章 世界のクレアチニン測定市場－市場の定義と概要

第3章 世界のクレアチニン測定市場－エグゼクティブサマリー

• 市場の内訳：製品別
• 市場の内訳：サンプルタイプ別
• 市場の内訳：方法別
• 市場の内訳：エンドユーザー別
• 市場の内訳：地域別

第4章 世界のクレアチニン測定市場－市場力学

• 市場に影響を与える要因
  • 促進要因
  • 抑制要因
  • 市場機会
  • 影響分析

第5章 世界のクレアチニン測定市場－業界分析

• サプライチェーン分析
• 価格分析
• アンメットニーズ

第6章 世界のクレアチニン測定市場－COVID-19分析

• 市場のCOVID-19分析
  • COVID-19以前の市場シナリオ
  • 現在のCOVID-19の市場シナリオ
  • COVID-19以後の市場シナリオ/将来の市場シナリオ
• COVID-19における価格の力学
• 需要と供給のスペクトル
• パンデミック時の市場に関連する政府のイニシアチブ
• メーカーの戦略的イニシアチブ
• 結論

第7章 世界のクレアチニン測定市場：製品別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）：製品別
  • 市場魅力指数：製品別
• 試薬*
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
• キット

第8章 世界のクレアチニン測定市場：サンプルタイプ別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）：サンプルタイプ別
  • 市場魅力指数：サンプルタイプ別
• 血液/血清*
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
• 尿

第9章 世界のクレアチニン測定市場：方法別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）：方法別
  • 市場魅力指数：方法別
• Kinetic Jaffe法*
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
• 酵素法

第10章 世界のクレアチニン測定市場：エンドユーザー別

• イントロダクション
  • 市場規模分析、および前年比成長分析（％）：エンドユーザー別
  • 市場魅力指数：エンドユーザー別
• 病院*
  • イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）
• 診断ラボ
• その他

第11章 世界のクレアチニン測定市場：地域別

• イントロダクション
  • 市場規模分析、100万米ドル（2020年～2029年）、および前年比成長分析（％）（2021年～2029年）：地域別
  • 市場魅力指数：地域別
• 北米
• 欧州
• 南米
• アジア太平洋
• 中東とアフリカ

第12章 世界のクレアチニン測定市場－競合情勢

• 主な開発と戦略
• 企業シェア分析
• 製品のベンチマーク
• 注目すべき主要企業のリスト

第13章 世界のクレアチニン測定市場－企業プロファイル概要

• Merck SA*
  • 企業概要
  • 製品ポートフォリオおよび説明
  • 主要ハイライト
  • 財務概要
• F. Hoffmann-la Roche ltd.
• Abbott Laboratories
• Thermo Fisher Scientific
• Beckman Coulter, Inc.
• Siemens Healthineers
• Randox Laboratories
• Pointe Scientific
• SENTINEL CH. SpA
• Diazyme Laboratories

第14章 世界のクレアチニン測定市場－DataM

• 付録
• 当社・アプリケーションについて
• お問い合わせ

Market Overview

The global creatinine measurement market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Muscle contractions in the human body produce creatinine. The kidneys' glomeruli extract creatinine from the blood and excrete it in the urine. The creatinine test is a sensitive diagnostic for determining the kidney's glomerular filtration rate. As a result, the creatinine test is widely used to assess renal function. Direct and automation-ready procedures for monitoring creatinine content in biological samples are gaining prominence in research and drug development.

Market Dynamics

Technological advancement in the detection of creatinine is expected to drive market growth.

A singlemode fiber-multicore fiber-multimode fiber-singlemode fiber (SMFMCF-MMF-SMF)-based biosensor construction that detects creatinine in the human body is simple, portable, and sensitive. To generate strong evanescent waves, chemical etching was employed to reduce the diameter of the sensing probe to 90 m. (EWs). Graphene oxide (GO), gold nanoparticles (AuNPs), molybdenum disulfide nanoparticles (MoS2-NPs), and the creatininase (CA) enzyme are used to functionalize the sensor probe. Fiber optic localized surface plasmon resonance assesses creatinine concentration (LSPR). Two-dimensional (2D) materials (GO and MoS2-NPs) are utilized to promote biocompatibility, and CA is used to increase probe specificity, while EWs are employed to enhance the LSPR impact of AuNPs.

Additionally, HR-TEM and UV-visible spectroscopy are also used to analyze and evaluate nanoparticles' shape and absorption spectra (NPs). The NPs adsorbed on the surface of the fiber probe are characterized using SEM. The sensor probe's reusability, repeatability, stability, selectivity, and pH test findings are also examined to ensure sensor performance. The suggested sensor has a sensitivity of 0.0025 nm/M, a standard deviation of 0.107, and a limit of 128.4 m over a linear detection range of 0 - 2000 m over a linear detection range of 0 - 2000 m. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Lack of predictive value provided by creatinine measurement techniques, presence and availability of global brands and the impediments they face due to big or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes, healthcare professionals turning their attention to novel renal dysfunction biomarkers and stringent regulatory policies are some factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Most of the symptoms linked to the new coronavirus pandemic have been respiratory illnesses ranging in severity from mild to life-threatening. However, due to the virus's kidney tropism, COVID-19 patients are increasingly displaying indicators of kidney damage, such as minor proteinuria, hematuria, acute kidney injury, or high creatinine levels, which could increase demand for creatinine measurement solutions. More than 40% of individuals hospitalized because of COVID-19 had kidney dysfunction. Furthermore, because persons with established kidney and other chronic illnesses have weakened immune systems, they are more susceptible to infection, making renal health a top issue. In response to these concerns, many guidelines, such as the IFFC Guide on COVID-19, advocate measuring creatinine in COVID-19 patients to detect potential kidney impairment early.

Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Jaffe's Kinetic Method segment is expected to hold the largest market share in creatinine measurement market

The jaffe's kinetic method segment is expected to dominate in 2020. The segment's growth benefits because it is the oldest and most widely used method for determining creatinine levels in clinical samples. The chemicals and kits used in Jaffe's kinetic technique are widely available and cost-effective. For instance, The measurement range of the Randox Jaffe Creatinine Assay is 16-2448mol/l, allowing for easy detection of clinically significant results. For convenience and ease of use, it is offered in a liquid ready-to-use version. Furthermore, it offers applications that specify instrument-specific settings for using the Randox Jaffe creatinine assay on a range of clinical chemistry analyzers. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.

Geographical Analysis

North America region holds the largest market share in the global creatinine measurement market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of kidney disorders, availability of well-developed healthcare infrastructure, rising awareness about preventive healthcare and the adoption of testing in the region are some factors the market is expected to boost in the forecast period. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases, Chronic kidney disease (CKD) affects nearly one-seventh of all adults in the United States or 37 million people. CKD risk is much higher for Americans with diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of diabetics and one-fifth of those with high blood pressure. Heart disease and a family history of renal failure are two more risk factors for kidney disease.

Even though kidney illness is common in the United States, 9 out of 10 people with the disease are unaware of it. Moreover, Early-stage kidney disease normally has no symptoms, and many individuals aren't aware they have it until it's too late. Kidney disease generally worsens over time, leading to kidney failure and other health issues, including stroke or heart attack. End-stage kidney disease (ESKD) is a kind of renal failure treated with a kidney transplant or dialysis. Therefore, it has increased the demand for creatinine measurement kits and reagents. Thus, the North American region is expected to hold the largest market share in the forecast period.

Global Creatinine Measurement Market - Competitive Landscape

Major key players in the creatinine measurement market are Merck SA, F. Hoffmann-la Roche ltd., Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, Randox Laboratories, Pointe Scientific, SENTINEL CH. SpA and Diazyme Laboratories.

Thermo Fisher Scientific:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and is based in Waltham, Massachusetts. The company offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

Invitrogen Creatinine Urinary Detection Kit: The Creatinine Urinary Detection research-use-only kit is a colorimetric assay designed to quantify and detect creatinine in human, rat, dog and monkey urine samples. Mouse urine samples are not compatible with the use of this assay for the detection of glomerular filtration rate (creatinine clearance).

Why Purchase the Report?

Visualize the composition of the creatinine measurement market segmentation by product, type of sample, method, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in creatinine measurement market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of creatinine measurement market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global creatinine measurement market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Creatinine Measurement Market - By Product

Reagents

Kits

Global Creatinine Measurement Market - By Type of Sample

Blood/serum

Urine

Global Creatinine Measurement Market - By Method

Jaffe's kinetic method

Enzymatic method

Global Creatinine Measurement Market - By End user

Hospitals

Diagnostic Laboratories

Others

Global Creatinine Measurement Market - By Region

North America

South America

Europe

Asia

Middle East & Africa

Table of Contents

1. Global Creatinine Measurement Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Creatinine Measurement Market - Market Definition and Overview

3. Global Creatinine Measurement Market - Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Type of Sample
• 3.3. Market Snippet by Method
• 3.4. Market Snippet by End User
• 3.5. Market Snippet by Region

4. Global Creatinine Measurement Market - Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Technological advancement in the detection of creatinine is expected to drive market growth.
  • 4.1.2. Restraints:
    • 4.1.2.1. Strict regulatory policies by the government are expected to hamper the market growth.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Global Creatinine Measurement Market - Industry Analysis

• 5.1. Supply Chain Analysis
• 5.2. Pricing Analysis
• 5.3. Unmet Needs

6. Global Creatinine Measurement Market - COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Creatinine Measurement Market - By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product Segment
• 7.2. Reagents*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Kits

8. Global Creatinine Measurement Market - By Type of Sample

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 8.1.2. Market Attractiveness Index, By Type of Sample Segment
• 8.2. Blood/serum*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Urine

9. Global Creatinine Measurement Market - By Method

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 9.1.2. Market Attractiveness Index, By Method Segment
• 9.2. Jaffe's kinetic method*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Enzymatic method

10. Global Creatinine Measurement Market - By End user

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.1.2. Market Attractiveness Index, By End user Segment
• 10.2. Hospitals*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Diagnostic laboratories
• 10.4. Others

11. Global Creatinine Measurement Market - By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. U.K.
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Sample
  • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
  • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Creatinine Measurement Market - Competitive Landscape

• 12.1. Key Developments and Strategies
• 12.2. Company Share Analysis
• 12.3. Product Benchmarking
• 12.4. List of Key Companies to Watch

13. Global Creatinine Measurement Market- Company Profiles

• 13.1. Merck SA*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Key Highlights
  • 13.1.4. Financial Overview
• 13.2. F. Hoffmann-la Roche ltd.
• 13.3. Abbott Laboratories
• 13.4. Thermo Fisher Scientific
• 13.5. Beckman Coulter, Inc.
• 13.6. Siemens Healthineers
• 13.7. Randox Laboratories
• 13.8. Pointe Scientific
• 13.9. SENTINEL CH. SpA
• 13.10. Diazyme Laboratories

LIST NOT EXHAUSTIVE

14. Global Creatinine Measurement Market - DataM

• 14.1. Appendix
• 14.2. About Us and Applications
• 14.3. Contact Us